Australian Red Cross Report issue

Foundation Phase 2 Phase 3

Organization Overview

First Clinical Trial
2016
NCT02745041
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Australian Red Cross